SUBSCRIBE: Print / Digital / eNewsletter
Risankizumab (SKYRIZI, AbbVie), outperformed secukinumab (Cosentyx, Novartis) in a head-to-head phase 3 study comparing the two treatments in adult patients with moderate to severe plaque psoriasis, according to data released by the company Jan. 14.
By the end of a three-day weekend, five of the teams at Hacking Dermatology's 2019 Hackathon walked away with $5,000 each. Learn more about the collaboration that took place and the solutions each team developed to solve pressing problem areas in dermatology.
Merz announced the launch of Belotero Revive, Friday, April 5, in selected countries in Europe and Latin America.
New drugs, data and guidelines on acne and rosacea treatment were among the takeaways from days two and three of MauiDerm 2014. Presenters also described evidence-based suggestions for managing pigmentary disorders and updated information on infectious diseases.
We now have three neurotoxins in our marketplace. Do you feel that these neurotoxins differ, and if so, how? An expert panel addresses the topic at the 2013 Vegas Cosmetic Surgery and Aesthetic Dermatology meeting.
Which products do you use and in which plane do you inject when rejuvenating the temple? A panel of experts in dermatology and plastic surgery identify their preferences for devices and techniques for temple revolumization.
Medical students can better identify and diagnose skin cancer after learning how to use a dermatoscope, researchers have found.
Patients with severe psoriasis who were treated systemically with biologic agents or methotrexate had a lower combined risk of death, myocardial infarction and stroke, according to the results of a recent study.
The use of polyalkylimide filler in patients with HIV-related facial lipoatrophy is associated with a high risk of infectious complications, which can occur years after treatment, according to a recent study.
The Food and Drug Administration has approved Sorilux Foam 0.005 percent for the topical treatment of plaque psoriasis of the scalp.
We've noticed that you're using an ad blocker
Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.
